#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma recurrent Crohn's disease Enteritis Sarcoidosis Wolfram syndrome Pneumonia Neuropathic arthropathy B-cell lymphoma refractory Renal cancer metastatic Leukocyte adhesion deficiency Craniocerebral injury Hypophosphatasia Glomerulonephritis membranous Hairy cell leukaemia Penile squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Proteus syndrome Rhabdomyosarcoma – Trials in Disease Soft tissue sarcoma – Treatment Idiopathic pulmonary fibrosis – Diagnostics IgA nephropathy – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Haemophilia B with anti factor IX – Diagnostics X-linked lymphoproliferative syndrome – Basic Information Mucopolysaccharidosis I – Life with Disease Systemic sclerosis pulmonary – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rasagiline Trazodone Corylus Avellana L. Abc-15Bo-116 Fludarabine Phosphate Ph. Eur. Cart 19/22 T Cells Tamsulosin Hydrochloride L-METHIONINE Mebufotenin Emrusolmin Tomligisiran Absk021 Hydrochloride Hydrate Fludeoxyglucose (18F) Golcadomide Sonelokimab ALENDRONATE SODIUM TRIHYDRATE L-ALANINE Syn321 Gsk3739937 Olive Oil, Refined More therapies…

    Learn about Your Condition

    Stomatitis Radicular pain Ventricular tachycardia Mucous membrane pemphigoid Periarthritis Propionic acidaemia Small intestine adenocarcinoma Ventricular fibrillation Post procedural hypotension Laryngeal cancer Fibromyalgia Chordoma Renal cancer metastatic Thymoma malignant Relapsing multiple sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Safety and Effects of AMT-162 Gene Therapy for Adults with SOD1 ALS

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE RH10 ENCODING MIRNA AGAINST SOD1 MRNA
    Sweden

  • Study on Atogepant for Preventing Menstrual Migraine in Women

    Not recruiting

    3 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atogepant
    Czechia Germany Hungary Italy Poland Portugal +1

  • Study on Pramipexole for Treating Restless Legs in Women with X-linked Adrenoleukodystrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Adrenoleukodystrophy
    • Restless legs syndrome
    Investigated Drugs:
    • Pramipexole Dihydrochloride Monohydrate
    The Netherlands

  • Study on PRAX-628 for Adults with Focal Onset or Generalized Tonic-Clonic Seizures

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    • Partial seizures
    Investigated Drugs:
    • Prax-628
    Germany Spain

  • Study on the Effects of Cladribine on Brain Cells in Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Cladribine
    Finland

  • Study on How Exenatide Affects Early Parkinson’s Disease Progression in Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Exenatide
    Sweden
Previous Page
1 … 91 92 93 94 95 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!